Delivery Order SPE2DB22D1017-SPE2DB25FE7CY

Award Date 10/10/24
Potential Completion Date 10/11/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with identification number SPE2DX16D1914|SPE2DX24FNNT8, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of levofloxacin dextrose, a pharmaceutical product, with a ceiling value of $1,083.92 and a completion date of April 10, 2024. This is a firm fixed price delivery order contract, which is a common contract type used by DLA to...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,366.30 delivery order contract is for the supply of 4567898899 ! LEVETIRA 500MG/5ML 10S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 9, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a pharmaceutical product, LEQEMBI 500 MG/5 ML VIAL 5ML, with a ceiling value of $2,188.25. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that serves the U.S. government. The $21,974.10 firm fixed price delivery order is for the supply of the prescription medication Leqvio, with a completion date of July 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,255.50, is a delivery order for the medical product "LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML". The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product, with a ceiling value of $18,604.40 and a period of performance ending on June 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,248.06 firm fixed-price delivery order is for the supply of LEVEMIR 100 UNIT/ML VIAL 10ML, a prescription medication. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,302.20 delivery order contract is for the supply of the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract is a firm fixed-price arrangement with a period of performance through May 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a $57,649.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $425,549.74, is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The IDC enables efficient government procurement of a...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE7CY
    Delivery Order

This delivery order (SPE2DB22D1017|SPE2DB25FE7CY) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,842.04 firm fixed-price contract is for the supply of 4,566,077,836 milliliters of the antibiotic Levofloxacin 25 mg/mL solution. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and DLA Troop Support Medical, which enables the agency to efficiently procure a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of October 11, 2024 and does not utilize any set-aside designations.

Generated 1/9/25, 9:11 AM